Myriad: Q2 Earnings Snapshot
By AP News
Published - Aug 06, 2024, 05:28 PM ET
Last Updated - Aug 06, 2024, 05:28 PM EDT
SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Myriad Genetics Inc. (MYGN) on Tuesday reported a loss of $36.7 million in its second quarter.
On a per-share basis, the Salt Lake City-based company said it had a loss of 41 cents. Earnings, adjusted for stock option expense and asset impairment costs, came to 5 cents per share.
The results beat Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 1 cent per share.
The molecular diagnostic company posted revenue of $211.5 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $205.5 million.
